Business

LEEF Brands Comments on Federal Cannabis Rescheduling and Potential to Participate in Nationwide CBD Program

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today commented on the issuance of an executive order by President Donald Trump directing agencies to begin the rescheduling of cannabis under the U.S. Controlled Substances Act. The executive order initiates the reclassification of cannabis from Schedule I to Schedule III, removing it from the most restrictive category under federa

articleLeef Brands IncDecember 18, 20254/company/leef-brands-inc/news/leef-brands-comments-federal-cannabis-003200049
LEEF Brands Comments on Federal Cannabis Rescheduling and Potential to Participate in Nationwide CBD Program

About this update from Leef Brands Inc

[{"type":"image","alt":"LEEF Brands Inc.","displaySize":"","headline":null,"caption":"LEEF Brands Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":232,"url":"https://media.zenfs.com/en/globenewswire.com/fd96d2b25e896aaa9233eb8dfe354658"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fveWigFwthXJyfYpn.AwgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/fd96d2b25e896aaa9233eb8dfe354658","width":300,"height":232}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today commented on the issuance of an executive order by President Donald Trump directing agencies to begin the rescheduling of cannabis under the U.S. Controlled Substances Act.","length":344,"tagName":"p"},{"type":"text","content":"The executive order initiates the reclassification of cannabis from Schedule I to Schedule III, removing it from the most restrictive category under federal law. This will improve operating economics for licensed operators, enable expanded medical research, and further the normalization of the regulated cannabis industry.","length":323,"tagName":"p"},{"type":"text","content":"“Cannabis rescheduling is a meaningful and long-awaited step forward for patients, research, and operators,” said Micah Anderson, Chief Executive Officer of LEEF Brands. “For LEEF, Schedule III removes the 280E tax burden, improving cash flow and allowing us to reinvest more efficiently in our people, facilities, and long-term growth. Just as importantly, it supports broader medical research and further legitimizes cannabis within the healthcare system.”","length":458,"tagName":"p"},{"type":"text","content":"LEEF operates state-of-the-art extraction, manufacturing, and cultivation facilities serving licensed brands across California and New York. The Company believes the removal of 280E will strengthen balance sheets across the sector and provide more growth capital for companies like LEEF to accelerate expansion plans.","length":317,"tagName":"p"},{"type":"text","content":"“From a financial perspective, rescheduling has the potential to materially improve access to capital across the cannabis industry,” said Kevin Wilson, Chief Financial Officer of L...

More updates from Leef Brands Inc

LEEF Brands, Inc.The CompanyLEEFCannabis reschedulingLEEF Brandscannabis industrymedical researchCompanyForward-Looking Statements